Moderate to Severe Plaque Psoriasis
4 competing products in clinical development for Moderate to Severe Plaque Psoriasis.
Pipeline by Phase
Phase 22
Phase 31
Approved1
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| KHK4827 + Placebo | Kyowa Kirin | Phase 3 | Completed | 40 |
| Placebo + SCD-044_Low Dose (Dose 1) + SCD-044_Intermediate Dose (Dose 2) + SCD-044_High Dose (Dose 3) | Sun Pharmaceutical | Phase 2 | Completed | 35 |
| KHK4827-Active + KHK4827-Placebo | Kyowa Kirin | Approved | Withdrawn | 35 |
| KHK4827 + Placebo | Kyowa Kirin | Phase 2 | Completed | 35 |